Lettieri Antonella, Oleari Roberto, Paganoni Alyssa J J, Gervasini Cristina, Massa Valentina, Fantin Alessandro, Cariboni Anna
CRC Aldo Ravelli for Neurotechnology and Experimental Brain Therapeutics, Università degli Studi di Milano, Milan, Italy.
Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Front Cell Dev Biol. 2021 Apr 1;9:638674. doi: 10.3389/fcell.2021.638674. eCollection 2021.
CHD7 is a chromatin remodeler protein that controls gene expression the formation of multi-protein complexes with specific transcription factors. During development, CHD7 controls several differentiation programs, mainly by acting on neural progenitors and neural crest (NC) cells. Thus, its roles range from the central nervous system to the peripheral nervous system and the organs colonized by NC cells, including the heart. Accordingly, mutated is linked to CHARGE syndrome, which is characterized by several neuronal dysfunctions and by malformations of NC-derived/populated organs. Altered CHD7 has also been associated with different neoplastic transformations. Interestingly, recent evidence revealed that semaphorins, a class of molecules involved in developmental and pathological processes similar to those controlled by CHD7, are regulated by CHD7 in a context-specific manner. In this article, we will review the recent insights that support the existence of genetic interactions between these pathways, both during developmental processes and cancer progression.
CHD7是一种染色质重塑蛋白,它通过与特定转录因子形成多蛋白复合物来控制基因表达。在发育过程中,CHD7主要通过作用于神经祖细胞和神经嵴(NC)细胞来控制多个分化程序。因此,其作用范围从中枢神经系统到外周神经系统以及由NC细胞定植的器官,包括心脏。相应地,CHD7突变与CHARGE综合征有关,该综合征的特征是多种神经元功能障碍以及NC衍生/定植器官的畸形。CHD7改变也与不同的肿瘤转化有关。有趣的是,最近的证据表明,信号素(一类参与与CHD7所控制的发育和病理过程相似的分子)在特定背景下受CHD7调控。在本文中,我们将综述最近的见解,这些见解支持了在发育过程和癌症进展过程中这些途径之间存在遗传相互作用。